Cureus . A Review of Cardiac Complications in Coronavirus Disease 2019

[tetano]

Cureus


. 2020 May 8;12(5):e8034.
doi: 10.7759/cureus.8034.
A Review of Cardiac Complications in Coronavirus Disease 2019


Romil Singh ¹ , Rahul Kashyap ² , Anneka Hutton ³ , Munish Sharma ⁴ , Salim Surani ^{4 5}



Affiliations

• PMID: 32528770
• PMCID: PMC7282366
• DOI: 10.7759/cureus.8034

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.

Keywords: cardiomyopathy; covid 19; heart failure; novel coronavirus; sars-cov-2.